Should I repeat the urinalysis after gonorrhea treatment because the post‑treatment urine shows microscopic hematuria with 3–10 red blood cells per high‑power field?

Should You Recheck Urinalysis After Gonorrhea Treatment?

No, you should not immediately recheck the urinalysis for microscopic hematuria (3-10 RBCs/HPF) found after gonorrhea treatment—this finding is likely unrelated to the gonorrhea itself and requires separate evaluation based on hematuria risk stratification, not as a test-of-cure for gonorrhea.

Understanding the Clinical Context

The microscopic hematuria you've discovered is almost certainly not a manifestation of gonorrhea or its treatment. Gonorrhea causes urethritis, not hematuria. The CDC guidelines are clear that test-of-cure is not recommended for gonorrhea patients treated with recommended regimens unless symptoms persist, therapeutic noncompliance is suspected, or reinfection is likely 1. The urinalysis showing blood is addressing a completely different clinical question than gonorrhea treatment success.

The Hematuria Requires Its Own Evaluation

Timing of Repeat Urinalysis

If you suspect the hematuria might be related to a concurrent urinary tract infection (UTI):

• Wait approximately 12 weeks before rechecking the urinalysis 2
• Recent evidence shows that 50% of UTI-related hematuria resolves by 60 days, and 75% by 180 days
• Rechecking earlier than 4 weeks significantly increases false-positive rates
• Optimal timing is around 12 weeks to allow natural resolution while keeping the rate of persistent positive results below 21% 2

If No UTI Was Present

The hematuria finding of 3-10 RBCs/HPF constitutes microscopic hematuria requiring risk stratification per current AUA/SUFU guidelines 3:

Risk Stratification Factors:

• Age: >35 years increases risk
• Sex: Male gender increases risk
• Smoking history: Current or former smoking
• Degree of hematuria: 3-10 RBCs/HPF is low-grade
• Gross hematuria history: Presence increases risk
• Occupational exposures: Chemical or dye exposure
• History of pelvic irradiation
• Chronic irritative voiding symptoms

Algorithmic Approach to the Hematuria

Step 1: Confirm the hematuria is real

• Ensure the specimen was properly collected and not contaminated
• Rule out menstruation, vigorous exercise, recent urologic procedures, or sexual activity as transient causes
• The finding should be confirmed on a second properly collected urinalysis 3, 4

Step 2: Rule out glomerular causes

• Check for dysmorphic RBCs, RBC casts, proteinuria, elevated creatinine, or hypertension
• If present, concurrent nephrology referral is needed 4, 5

Step 3: Apply risk stratification 3

• Low-risk: Female, age <35, non-smoker, 3-10 RBCs/HPF, no other risk factors

  • May repeat UA in 6-12 months through shared decision-making
  • Consider discharge from urologic care if repeat UA is negative

• Intermediate-risk: One or more risk factors present

  • Cystoscopy + renal/bladder ultrasound recommended

• High-risk: Multiple risk factors, age >50, heavy smoking history, occupational exposures

  • Cystoscopy + CT urography (multiphasic) recommended 6, 4

Common Pitfalls to Avoid

1. Don't confuse gonorrhea follow-up with hematuria evaluation: These are separate clinical entities requiring different management pathways

2. Don't recheck UA too early: If UTI was present, waiting <12 weeks leads to unnecessary further workup 2

3. Don't ignore persistent hematuria: Even low-grade microscopic hematuria (3-10 RBCs/HPF) can indicate malignancy in up to 5% of cases, particularly in high-risk patients 4

4. Don't order voided urine cytology routinely: This is no longer recommended for asymptomatic microscopic hematuria screening unless high-risk features are present 4, 7

5. Don't assume anticoagulation explains the hematuria: Anticoagulant use does not alter the need for hematuria evaluation 6

Practical Next Steps

If the patient had concurrent UTI symptoms:

• Treat the UTI appropriately
• Recheck UA at 12 weeks post-treatment 2
• If hematuria persists, proceed with risk-stratified evaluation

If no UTI was present:

• Obtain a second confirmatory UA on a properly collected specimen
• If confirmed, perform risk stratification
• Proceed with appropriate evaluation based on risk category (observation vs. cystoscopy ± imaging)

Regarding the gonorrhea:

• No test-of-cure needed unless symptoms persist or reinfection/noncompliance suspected 1
• Retest for gonorrhea at 3-6 months to detect reinfection (not treatment failure) 1
• Ensure partner treatment and counsel on abstinence until treatment complete

The key insight is recognizing these are two separate clinical problems requiring distinct management algorithms. The hematuria evaluation should proceed independently based on established risk stratification, not as part of gonorrhea follow-up.